Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Advanced Breast Cancer: Expert Perspectives On Recent Progress
EP. 1: Perspectives on Recent Progress: Program Overview
July 14th 2020
EP. 2: Phase 3 KEYNOTE-355 Overview
July 14th 2020
EP. 3: PD-L1 Testing Standard of Practice
July 14th 2020
EP. 4: KEYNOTE-355 Regimen’s Role in Treatment Paradigm
July 14th 2020
EP. 5: ASCO New Data: PARP Inhibitors
July 14th 2020
EP. 6: SWOG S1416 and TBCRC 048 Phase 2 Trial Overviews
July 14th 2020
EP. 7: Phase 3 ASCENT Regimen Accelerated Approval
July 14th 2020
EP. 8: Next-Generation Sequencing: Triple Negative Breast Cancer
July 14th 2020
EP. 9: CDK4/6 Inhibition in HR+ Metastatic Breast Cancer
July 14th 2020
EP. 10: CDK4/6 Clinical Trial Survival Data Impact
July 14th 2020
EP. 11: CDK4/6 Meta-Analysis Data
July 14th 2020
EP. 12: Mechanisms of Resistance to CDK4/6 Inhibitors
July 14th 2020
EP. 13: Significance of PIK3CA Mutation in HR+ Breast Cancer
July 14th 2020
EP. 14: After Progression on PIK3CAi Therapy: MTOR Inhibition
July 14th 2020
EP. 15: HER2+ MBC Adverse-Event Management
July 14th 2020
EP. 16: Notable ASCO Trial Updates
July 14th 2020